Personalized obesity care combining medication and lifestyle delivers better, longer-lasting weight loss and health outcomes. When diet and exercise wave the white flag, real medicine rolls in like the superhero with a prescription pad! Dr. Alex McDonald and Dr. Regina Regasa explore obesity’s health impact and a multifaceted approach for effective care. Orforglipron, a daily oral GLP-1 pill, matches Ozempic in Phase 3 trial, offering a needle-free option for Type 2 diabetes. Black youth with dysglycemia show reduced insulin clearance, possibly contributing to β-cell dysfunction and ... Real-world weight loss with semaglutide or tirzepatide is lower due to early discontinuation and low maintenance dosing. Nearly half of U.S. patients discontinued semaglutide within 5 months, with cost a key barrier to continued use. How many medications are FDA-approved for the long-term use of treating obesity? Habits collapsed, health's calling 'Mayday'! The doc soars in ... time to dose the FDA way! Obesity care must be evidence-based and patient-centered, says Dr. Auriemma in this call for science-driven treatment. Obesity is a chronic, complex disease driven by biology, not just behavior—effective care requires empathy and support. A new study investigated the effects of physical training on aging in the skeletal muscle of people with obesity. Researchers report a sharp increase in extreme forms of obesity in the U.S. The guideline supports "value- and preference-sensitive decision-making" for children with obesity and their families. The use of tirzepatide in patients with obstructive sleep apnea and obesity improves both OSA severity and metabolic issues. Semaglutide reduced major CVD risk by 20% in adults with overweight or obesity, but not diabetes. In a recent study, Paige Weaver, from the Department of Pharmacy at the Ascension Genesys Hospital in Grand Blanc, ... A recent study shows a link between obesity and cancer. The study, published in journal Obesity, suggests that ... Bariatric surgery significantly reduces the risk of cancer, especially obesity-related cancers, by as much as half in ... Obesity is on the rise in adolescents; nearly one in five people aged 2 to 19 years are obese. One strategy for weight ...